Gene therapy for cystic fibrosis shows encouraging trial results
A therapy that replaces the faulty gene responsible for cystic fibrosis in patients’ lungs has produced encouraging results in a major UK trial. One hundred and thirty six patients aged 12 and over received monthly doses of either the therapy or the placebo for one year. The clinical trial reached its primary endpoint with patients […]
